100041-05-2(flazin) Price
This page is the exclusive Price page for 100041-05-2(flazin).
This page is dedicated to presenting you with the most accurate and real-time updated Price information about this important compound,thereby providing a strong basis for you when making relevant purchasing decisions and helping you understand the market Price dynamics more comprehensively and clearly.
flazin Price
| Related Categories | No. | Brand | Purity | Specification | Price | Update time | Buy |
|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | F51810-5 mg | acmec | 5mg | ¥5280.0 | 09 Sep. 2021 | ||
| TargetMol Chemicals | TN6094-5 mg | targetmol | 98% | 5mg | ¥ 12,500 | 11 Jul. 2023 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | F51810-5mg | acmec | 分析對(duì)照品,98.0% | 5mg | ¥5280.0 | 07 Sep. 2023 | |
| 1PlusChem | 1P00013J-5mg | 1pchem | 98% | 5mg | $1092.00 | 27 Dec. 2023 | |
| A2B Chem LLC | AA00623-5mg | a2bchem | 5mg | $660.00 | 20 Apr. 2024 | ||
| MedChemExpress | HY-141508-1mg | mce | 1mg | ¥4000 | 22 May. 2024 | ||
| MedChemExpress | HY-141508-5mg | mce | 5mg | ¥9900 | 22 May. 2024 | ||
| Ambeed | A1327703-5mg | ambeed | 97% | 5mg | $785.0 | 02 Jun. 2024 | |
| TargetMol Chemicals | TN6094-5mg | targetmol | 5mg | ¥ 10980 | 20 Jul. 2024 | ||
| Aaron | AR0001BV-5mg | aaron | 98% | 5mg | $753.00 | 13 Feb. 2025 | |
| Ambeed | A1327703-1mg | ambeed | 97% | 1mg | $532.0 | 01 Mar. 2025 |
Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
Audited Supplier
Gold Member
CN Supplier
Reagent
Company nature: Private enterprises
Xiamen PinR Bio-tech Co., Ltd.
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises
Shenzhen Yaoyuan R&D Center Co.,Ltd
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises
Hebei Liye chemical Co.,Ltd
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises